Rare diseases
Investigational molecules
Locations
Study on Ianalumab for Patients with Systemic Lupus Erythematosus
GermanyStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
GermanyStudy on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
GermanyStudy Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma
GermanyLong-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A
GermanyStudy Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer
GermanyStudy of Nivolumab and Relatlimab for Patients with Resectable Non-Small Cell Lung Cancer
GermanyStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
GermanyStudy Comparing Datopotamab Deruxtecan to Chemotherapy in Patients with Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
GermanyStudy on the Effects of DFV890 for Pain Relief in Patients with Knee Osteoarthritis
GermanyStudy Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients
GermanyStudy on Low Dose Rivaroxaban for Heart and Blood Vessel Disease in Patients with Advanced Kidney Disease or on Dialysis
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
